跳至主要内容
临床试验/CTRI/2025/03/082156
CTRI/2025/03/082156尚未招募3 期

Clinical evaluation of panchashireesh Agad churna pratisaran in tobacco chewing induced Sarvasar Mukhapaka (Oral Submucosal Fibrosis Grade 2)

Self1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2025年3月21日最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方
Self
入组人数
24
试验地点
1
主要终点
1.The reduction in the gradation of symptoms or complete alleviation in

研究概览

简要总结

The study will conducted after obtaining permission from institutional ethical committee and will be registered ctri India as per inclusion criteria.patient will be selected and screening done at OPD and IPD of Agadtantra

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Tobacco chewing since 2-3 years Patient having clinical symptoms of OSMF 2.

排除标准

  • Patient with recurrent stomatitis due to nuetritional deficiency Patient diagnosed with oral squamous cell carcinoma.

结局指标

主要结局

1.The reduction in the gradation of symptoms or complete alleviation in

时间窗: 28 days

symptoms of OSMF will reveal the efficacy of Panchashireesh Agad churna in OSMF Grade II

时间窗: 28 days

caused by Tobacco chewing.

时间窗: 28 days

次要结局

  • Worsening in the OSMF grade II symptoms will be measured as(secondary end point.)

研究者

发起方
Self
申办方类型
Other [Research institution and hospital Bharti vidyapeeth pune]
责任方
Principal Investigator
主要研究者

Dr.Uday Dipak Shelar

Bharati Vidyapeeth (Deemed To Be University)college Of Ayurved,Pune

研究点 (1)

Loading locations...

相似试验